HIGHLIGHTS
- who: Armin Spreco et al. from the Department of Health, Medicine, and Caring Sciences, University, have published the Article: Effectiveness of the BNT162b2 mRNA Vaccine Compared with Hybrid Immunity in Populations Prioritized and Non-Prioritized for COVID-19 Vaccination in 2021-2022: A Naturalistic Case-Control Study in Sweden, in the Journal: Vaccines 2022, 1273 of 31/07/2021
- what: The authors aimed to compare the effectiveness of the BNT162b2 mRNA_vaccine with hybrid immunity 180 days post-vaccination in population groups prioritized and not prioritized for vaccination. This study has strengths and limitations that should . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.